ACRP Expands Credentialing Program for Clinical Trial Investigators
ACRP announced changes to its investigator certification program
The Academy of Clinical Research Professionals today announced changes to its investigator certification program that will allow for broader credentialing of those performing the pivotal role of principal investigator in clinical trials.
The Academy Board of Trustees voted to change the eligibility criteria for its Certified Physician Investigator (CPI) program to allow for individuals with a doctorate-level degree, such as PhD, Pharm.D, DNP, to earn recognition of their clinical research-specific expertise through certification. The CPI program had previously been open only to individuals holding an active medical license.
As part of its expansion of the CPI program's eligibility criteria, the Academy Board also approved a program title change from Certified Physician Investigator to Certified Principal Investigator.
Applicants for the CPI program are still required to demonstrate active participation in the clinical trials process, but are no longer required to hold a current license to practice medicine.
"Because the CPI® program is designed to focus on the clinical research-specific competencies required of a clinical trial investigator, not medical knowledge, this change is more reflective of the scope and diversity of investigators involved in the clinical research process," says Deborah L. Rosenbaum, CCRC, CCRA, Academy Chair. "The changes announced today also provide greater standardization of the knowledge, skills, and abilities that can be expected from a certified individual performing the role of the investigator in clinical research."
ACRP is the only organization offering role-specific certification programs for clinical research professionals through its Certified Clinical Research Coordinator (CCRC), Certified Clinical Research Associate (CCRA), and Certified Principal Investigator (CPI) programs, all of which hold the distinction of being the only clinical research certification programs accredited by the National Commission for Certifying Agencies.
TransCelerate BioPharma recognizes ACRP's CCRC, CCRA, and CPI designations as evidence of Good Clinical Practice training, and American Nurses Credentialing Center recognizes ACRP's CCRC and CCRA designations toward assisting a hospital in meeting requirements of its Magnet Recognition Program.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
